...
首页> 外文期刊>Angewandte Chemie >Mechanistic Studies on the Conversion of Arylamines into Arylnitro Compounds by Aminopyrrolnitrin Oxygenase: Identification of Intermediates and Kinetic Studies
【24h】

Mechanistic Studies on the Conversion of Arylamines into Arylnitro Compounds by Aminopyrrolnitrin Oxygenase: Identification of Intermediates and Kinetic Studies

机译:氨基吡咯硝酸氧合酶将芳胺转化为芳硝基化合物的机理研究:中间体的鉴定和动力学研究

获取原文
获取原文并翻译 | 示例
           

摘要

Rieske oxygenases are widespread in nature and catalyze a diverse set of oxidation reactions including cis-dihydroxylation, monohydroxylation, desaturation, sulfoxidation, and O- and N-dealkylation.[1], [2] Recently, we reported the characterization of a Rieske N-oxygenase, aminopyrrolnitrin oxygenase (PrnD), which catalyzes unusual arylamine oxidation reactions.[3] Although arylamine oxidases seem to be widely distributed and used in a variety of metabolic reactions,[4]-[9] PrnD represents one of only two known examples of arylamine oxidases or N-oxygenases involved in the formation of nitro groups, the other being AurF involved in aureothin biosynthesis.[9] PrnD is involved in the biosynthesis of antibiotic pyrrolnitrin[3-chloro-4-(2-nitro-3-chlorophenyl)pyrrole] (1), which is produced by many Pseudomonads and displays broad-spectrum antifungal activity.[10] In the proposed biosynthetic pathway of 1 (Scheme 1),[11] PrnD catalyzes the oxidation of the amino group of aminopyrrolnitrin (2) to a nitro group to form 1. Although PrnD has been characterized, no experimental evidence has been available for the mechanism of conversion of the arylamine. Therefore, we decided to investigate the intermediates formed during the conversion of arylamine into arylnitro compounds, as these might provide valuable mechanistic information.
机译:Rieske加氧酶在自然界中广泛分布,并催化各种氧化反应,包括顺式-二羟基化,单羟基化,去饱和,硫氧化以及O-和N-脱烷基化。[1],[2]最近,我们报道了Rieske N的表征-加氧酶,氨基吡咯烷素加氧酶(PrnD),催化不寻常的芳基胺氧化反应。[3]尽管芳基胺氧化酶似乎已广泛分布并用于各种代谢反应,[4]-[9] PrnD代表参与硝基形成的芳基胺氧化酶或N-加氧酶只有两个已知的例子之一,另一个是AurF参与金黄色素的生物合成。[9] PrnD参与了抗生素吡咯硝酸酯[3-氯-4-(2-硝基-3-氯苯基)吡咯](1)的生物合成,吡咯硝酮由许多假单胞菌产生,并具有广谱抗真菌活性。[10]在拟议的1的生物合成途径中(方案1),[11] PrnD催化氨基吡咯硝酸(2)的氨基氧化为硝基形成1。尽管PrnD已被表征,但尚无实验证据可用于芳胺转化的机理。因此,我们决定研究在芳基胺转化为芳基硝基化合物的过程中形成的中间体,因为这些中间体可能提供有价值的机理信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号